Espace privéDéconnexion
Mot de passe 


  1. Anota A, Westeel V. Quality of life with durvalumab in stage III non-small-cell lung cancer. Lancet Oncol. 2019 Oct 7.
  2. Baudry AS, Vanlemmens L, Anota A, Cortot A, Piessen G, Christophe V. Profiles of caregivers most at risk of having unmet supportive care needs: Recommendations for healthcare professionals in oncology. Eur J Oncol Nurs. 2019 Dec;43:101669.
  3. Brédart A, Anota A, Dick J, Cano A, De Pauw A, Kop JL, Aaronson NK, Bleiker EM, Brunet J, Devilee P, Stoppa-Lyonnet D, Schmutzler R, Dolbeault S. The "Psychosocial Aspects in Hereditary Cancer" questionnaire in women attending breast cancer genetic clinics: Psychometric validation across French-, German and Spanish-language versions. Eur J Cancer Care (Engl). 2019 Sep 30:e13173.
  4. Brédart A, Kop JL, Dick J, Cano A, De Pauw A, Anota A, Brunet J, Devilee P, Stoppa-Lyonnet D, Schmutzler R, Dolbeault S. Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study. BMJ Open. 2019 Sep 24;9(9):e029926.
  5. Cottone F, Anota A, Bonnetain F, Collins GS, Efficace F. Propensity score methods and regression adjustment for analysis of nonrandomized studies with health-related quality of life outcomes. Pharmacoepidemiol Drug Saf. 2019 May;28(5):690-699.
  6. Cottone F, Deliu N, Collins GS, Anota A, Bonnetain F, Van Steen K, Cella D, Efficace F. Modeling strategies to improve parameter estimates in prognostic factors analyses with patient-reported outcomes in oncology. Qual Life Res. 2019  May;28(5):1315-1325.
  7. Charton E, Bachet JB, Hammel P, Desramé J, Chibaudel B, Cohen R, Debourdeau P, Dauba J, Lecomte T, Seitz JF, Tournigand C, Aparicio T, Guerin-Meyer V, Taieb J, Volet J, Louvet C, Anota A, Bonnetain F. Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial. Cancer Med. 2019 Sep;8(11):5079-5088.
  8. Charton E, Cuer B, Cottone F, Efficace F, Touraine C, Hamidou Z, Fiteni F, Bonnetain F, Woronoff-Lemsi MC, Bascoul-Mollevi C, Anota A. Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review. Qual Life Res. 2019 Nov 27.
  9. Cholley T, Thiery-Vuillemin A, Limat S, Hugues M, Calcagno F, Mouillet G, Anota A, Nerich V. Economic Burden of Metastatic Clear-Cell Renal Cell Carcinoma for French Patients Treated With Targeted Therapies. Clin Genitourin Cancer. 2018 Nov 7.
  10. Eberst G, Anota A, Scherpereel A, Mazieres J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D, Molinier O, Léna H, Rivière F, Monnet I, Gounant V, Janicot H, Gervais R, Locher C, Charton E, Morin F, Zalcman G, Westeel V; French Cooperative Thoracic Intergroup (IFCT). Health-Related Quality of Life  Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial. Clin Cancer Res. 2019 Oct 1;25(19):5759-5765.
  11. Fiteni F, Ray IL, Ousmen A, Isambert N, Anota A, Bonnetain F. Health-related quality of life as an endpoint in oncology phase I trials: a systematic review. BMC Cancer. 2019 Apr 16;1 9(1):361.
  12. Lazzarotto S, Martin F, Saint-Laurent A, Hamidou Z, Aghababian V, Auquier P, Baumstarck K. Coping with age-related hearing loss: patient-caregiver dyad effects on quality of life. Health Qual Life Outcomes. 2019 May 22;17(1):86.
  13. Mamguem Kamga A, Dumas A, Joly F, Billa O, Simon J, Poillot ML, Darut-Jouve A, Coutant C, Fumoleau P, Arveux P, Dabakuyo-Yonli TS. Long-Term Gynecological Cancer Survivors in Côte d'Or: Health-Related Quality of Life and Living Conditions. Oncologist. 2019 Jul;24(7):e490-e500
  14. Mouillet G, Fritzsch J, Paget-Bailly S, Pozet A, Es-Saad I, Meurisse A, Vernerey D, Mouyabi K, Berthod D, Bonnetain F, Anota A, Thiery-Vuillemin A. Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol. Health Qual Life Outcomes. 2019 Feb 4;17(1):25.
  15. Omorou AY, Achit H, Wieczorek M, Pouchot J, Fautrel B, Rat AC, Guillemin F. Impact of comorbidities and functional impairment on 5-year loss of health utility in patients with lower-limb osteoarthritis in the KHOALA cohort. Qual Life Res. 2019 Nov;28(11):3047-3054.
  16. Sparano F, Aaronson NK, Sprangers MAG, Fayers P, Pusic A, Kieffer JM, Cottone F, Rees J, Pezold M, Anota A, Charton E, Vignetti M, Wan C, Blazeby J, Efficace F. Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic review. BMJ Support Palliat Care. 2019 Nov 12.
  17. Van Hoye A, Omorou Y, Rotonda C, Gendarme S, Tarquinio C, Houtmann B, Peiffert D, Longo R, Martin-Krumm C. Psychological and social determinants of physical activity from diagnosis to remission among French cancer patients (PERTINENCE): protocol for a mixed-method study. BMC Public Health. 2019 Aug 6;19(1):1053.

Nos partenaires